Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update

Corium International Inc (CORI) - Product Pipeline Analysis, 2018 Update


  • Products Id :- GDME7972PD
  • |
  • Pages: 37
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Corium International Inc (Corium) is a commercial-stage biopharmaceutical company that produces and develops central nervous system pharmaceutical products. The company develops transdermal healthcare products with the help of Corplex technology platform using small molecules. Its products include Corplex Memantine and Corplex Donepezil for the treatment of Alzheimer's disease. Corium also develops MicroCor PTH for the treatment of osteoporosis using another technology platform called MicroCor system. The company provides proprietary development programs, contract research and development services. It partners with pharmaceutical and consumer products companies. The company operates through its research and development facility in Grand Rapids, the US. Corium is headquartered in Menlo Park, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Corium International Inc

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Corium International Inc Company Overview 5

Corium International Inc Company Snapshot 5

Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Corium International Inc - Pipeline Analysis Overview 7

Corium International Inc - Key Facts 7

Corium International Inc - Major Products and Services 8

Corium International Inc Pipeline Products by Development Stage 9

Corium International Inc Ongoing Clinical Trials by Trial Status 11

Corium International Inc Pipeline Products Overview 12

Corplex Donepezil Transdermal System 12

Corplex Donepezil Transdermal System Product Overview 12

Corplex Donepezil Transdermal System Clinical Trial 13

Corplex Memantine Transdermal System 14

Corplex Memantine Transdermal System Product Overview 14

Corplex Ropinirole Transdermal System 15

Corplex Ropinirole Transdermal System Product Overview 15

Island Dressing 16

Island Dressing Product Overview 16

MicroCor Transdermal System 17

MicroCor Transdermal System Product Overview 17

MicroCor Zolmitriptan System 18

MicroCor Zolmitriptan System Product Overview 18

MicroJet 19

MicroJet Product Overview 19

Rapidly Dissolving Film 20

Rapidly Dissolving Film Product Overview 20

Solid State Film 21

Solid State Film Product Overview 21

Corium International Inc - Key Competitors 22

Corium International Inc - Key Employees 23

Corium International Inc - Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

Corium International Inc, Recent Developments 25

Jul 11, 2018: Corium Announces Issuance of Additional U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer''s Disease 25

Jun 13, 2018: Corium Announces Issuance of Key U.S. Patent Covering Corplex Donepezil Transdermal System for Alzheimer's Disease 25

May 14, 2018: Corium Announces Second Quarter Fiscal 2018 Financial Results 26

Feb 08, 2018: Corium Reports First Quarter Fiscal 2018 Financial Results and Corporate Highlights 27

Nov 16, 2017: Corium Reports Fourth Quarter and Fiscal Year 2017 Financial Results and Corporate Highlights 28

Aug 03, 2017: Corium Reports Recent Corporate Highlights and Financial Results for Third Quarter Fiscal 2017 29

Jul 18, 2017: Corium Presents Clinical Results from Pilot Bioequivalence Study of Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017 30

Jul 06, 2017: Corium to Present Clinical Results from Pilot Bioequivalence Study of Once-weekly Corplex Donepezil Transdermal System at Alzheimer's Association International Conference 2017 30

May 11, 2017: Corium Reports Second Quarter Fiscal 2017 Financial Results and Recent Corporate Highlights 31

May 11, 2017: Corium Reports Positive Preliminary Results in Alzheimer's Clinical Study 32

Appendix 34

Methodology 34

About GlobalData 37

Contact Us 37

Disclaimer 37

List of Figures

Corium International Inc Pipeline Products by Equipment Type 6

Corium International Inc Pipeline Products by Development Stage 9

Corium International Inc Ongoing Clinical Trials by Trial Status 11

List of Tables

Corium International Inc Pipeline Products and Ongoing Clinical Trials Overview 5

Corium International Inc Pipeline Products by Equipment Type 6

Corium International Inc Pipeline Products by Indication 6

Corium International Inc Ongoing Clinical Trials by Trial Status 6

Corium International Inc, Key Facts 7

Corium International Inc, Major Products and Services 8

Corium International Inc Number of Pipeline Products by Development Stage 9

Corium International Inc Pipeline Products Summary by Development Stage 10

Corium International Inc Ongoing Clinical Trials by Trial Status 11

Corium International Inc Ongoing Clinical Trials Summary 11

Corplex Donepezil Transdermal System - Product Status 12

Corplex Donepezil Transdermal System - Product Description 12

Corplex Donepezil Transdermal System - Phase 1 Clinical Trial of Corplex Donepezil Transdermal System for the Treatment of Alzheimer's Disease 13

Corplex Memantine Transdermal System - Product Status 14

Corplex Memantine Transdermal System - Product Description 14

Corplex Ropinirole Transdermal System - Product Status 15

Corplex Ropinirole Transdermal System - Product Description 15

Island Dressing - Product Status 16

Island Dressing - Product Description 16

MicroCor Transdermal System - Product Status 17

MicroCor Transdermal System - Product Description 17

MicroCor Zolmitriptan System - Product Status 18

MicroCor Zolmitriptan System - Product Description 18

MicroJet - Product Status 19

MicroJet - Product Description 19

Rapidly Dissolving Film - Product Status 20

Rapidly Dissolving Film - Product Description 20

Solid State Film - Product Status 21

Solid State Film - Product Description 21

Corium International Inc, Key Employees 23

Corium International Inc, Other Locations 24

Glossary 36

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Agile Therapeutics Inc

ActiveCare Inc

BG Medicine Inc

Corium International Inc, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies

select a license
Single User License
USD 750 INR 53940
Site License
USD 1500 INR 107880
Corporate User License
USD 2250 INR 161820

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com